MEN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.189600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.315800E-01
Normal-vs-Stage2
3.332200E-01
Normal-vs-Stage3
6.032400E-02
Normal-vs-Stage4
3.842400E-01
Stage1-vs-Stage2
9.707200E-01
Stage1-vs-Stage3
3.677600E-02
Stage1-vs-Stage4
8.442400E-01
Stage2-vs-Stage3
2.792100E-02
Stage2-vs-Stage4
8.848600E-01
Stage3-vs-Stage4
1.158830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.122600E-01
Normal-vs-AfricanAmerican
7.443400E-01
Normal-vs-Asian
3.913400E-01
Caucasian-vs-AfricanAmerican
4.794800E-01
Caucasian-vs-Asian
7.175800E-01
AfricanAmerican-vs-Asian
7.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.139600E-01
Normal-vs-Female
4.417000E-01
Male-vs-Female
3.997600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.668800E-01
Normal-vs-Age(41-60Yrs)
5.001400E-01
Normal-vs-Age(61-80Yrs)
2.445000E-01
Normal-vs-Age(81-100Yrs)
3.229600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.187400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.873800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.067400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.187800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.878200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.518000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.459600E-01
Normal-vs-Daily Drinker
5.436800E-01
Normal-vs-Weekly Drinker
7.086000E-01
Normal-vs-Occasional Drinker
6.673200E-01
Normal-vs-Social Drinker
3.521400E-01
Non Drinker-vs-Daily Drinker
4.921600E-01
Non Drinker-vs-Weekly Drinker
2.026400E-01
Non Drinker-vs-Occasional Drinker
1.240650E-01
Non Drinker-vs-Social Drinker
8.624600E-01
Daily Drinker-vs-Weekly Drinker
6.165600E-01
Daily Drinker-vs-Occasional Drinker
5.305400E-01
Daily Drinker-vs-Social Drinker
6.888400E-01
Weekly Drinker-vs-Occasional Drinker
9.635800E-01
Weekly Drinker-vs-Social Drinker
3.654600E-01
Occasional Drinker-vs-Social Drinker
2.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.577800E-01
Normal-vs-Grade 2
8.968400E-01
Normal-vs-Grade 3
9.336000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.319800E-01
Grade 1-vs-Grade 3
1.652000E-01
Grade 1-vs-Grade 4
8.577800E-01
Grade 2-vs-Grade 3
2.380000E-01
Grade 2-vs-Grade 4
8.968400E-01
Grade 3-vs-Grade 4
9.336000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.254000E-01
Normal-vs-NonDiabetic
4.341600E-01
Diabetic-vs-NonDiabetic
2.204400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.830800E-01
Normal-vs-NoPancreatitis
3.026400E-01
Pancreatitis-vs-NoPancreatitis
4.704300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.583400E-01
Normal-vs-N1
3.559200E-01
N0-vs-N1
6.669000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.214800E-01
Normal-vs-TP53-NonMutant
4.482600E-01
TP53-Mutant-vs-TP53-NonMutant
5.887800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
